Nasdaq Stocks Posting Largest Volume Decreases

PTC Therapeutics Added to NASDAQ Biotechnology Index

Canterbury Park : Approximately shares changed hands, a 100.0 decrease from its 65-day average volume. The shares remained unchanged at $10.78. DNB Financial Corp. : Approximately shares changed hands, a 99.9 decrease from its 65-day average volume.
Source: http://www.businessweek.com/ap/2013-12-24/nasdaq-stocks-posting-largest-volume-decreases

NASDAQ-100 Index Additions to Ignore for Now

The company claims it creates solutions that enable secure connections for a smarter world. The former division of Phillips only recently changed its name to NXP. For a list of additions to the NASDAQ-100, NXP has one of the more attractive valuations. The stock trades at roughly 11 times forward earnings estimates and only around two times revenue forecasts.
Source: http://www.fool.com/investing/general/2013/12/23/nasdaq-100-index-additions-to-ignore-for-now.aspx

For one thing, the Nasdaq is not the same as it was in 2000, experts tell CNNMoney . “The Nasdaq has really grown up over the last decade. It’s a lot more mature now,” says Kim Forrest, senior equity analyst at Fort Pitt Capital. Conventional perception equates the Nasdaq with tech stocks, but its composition has changed.
Source: http://www.moneynews.com/InvestingAnalysis/Nasdaq-bubble-tech-stocks/2013/12/24/id/543578

Experts: Don’t see here Fear a Nasdaq Bubble

(Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO) The NASDAQ Biotechnology Index is designed to track the performance of a set of NASDAQ-listed securities classified as either Biotechnology or Pharmaceuticals. These companies must meet eligibility requirements, including minimum market capitalization, average daily trading volume, and seasoning as a public company, among other criteria. The NASDAQ Biotechnology Index is re-ranked semi-annually in May and November. For more information about the NASDAQ Biotechnology Index, including eligibility criteria, visit https://indexes.nasdaqomx.com/. About PTC Therapeutics, Inc.
Source: http://online.wsj.com/article/PR-CO-20131223-903317.html

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s